Idiopathic generalized epilepsies (IGEs) correspond to one-third of all epilepsies. Despite of this high frequency, IGEs remains underdiagnosed. Clinical features are the cornerstone to diagnosis. In this group all types of generalized seizures may occur such as generalized tonic-clonic, absences and myoclonic seizures. EEG is very supportive of IGEs diagnosis when it shows the typical generalized symmetrical, spike or polispyke and waves complexes with normal background. According to the main seizure type and the age of onset, IGEs are divided in subsyndromes. The importance of the correct diagnosis is supported by the high rate of seizure free patients under appropriate antiepileptic drug therapy. On the other hand, the use of some antiepileptic drugs such as carbamazepine or phenytoin may exacerbate the seizures or even induce status epilepticus in some subsyndromes. In this article, the main antiepileptic drugs used in the treatment of IGEs are reviewed as well as some practical issues for IGEs subsyndromes treatment.14SUPPL. 22024Panayiotopoulos, C.P., Idiopathic generalized epilepsies (2005) The Epilepsies: Seizures, Syndromes and Management, pp. 271-348. , Panayiotopoulos CP, ed. Oxford: Bladon Medical PublishingProposal for revised classification of epilepsies and epileptic syndromes (1989) Epilepsia, 30, pp. 389-399. , Commission on Classification and Terminology of the International League Against EpilepsyBetting, L.E., Mory, S.B., Lopes-Cendes, I., Li, L.M., Guerreiro, M.M., Guerreiro, C.A.M., Cendes, F., EEG features in idiopathic generalized epilepsy: Clues to diagnosis (2006) Epilepsia, 47 (3), pp. 523-528. , DOI 10.1111/j.1528-1167.2006.00462.xRudolph, U., Crestani, F., Benke, D., Benzodiazepine actions mediated by specific GABAA receptor subtypes (1999) Nature, 401, pp. 796-800Patsalos, P.N., Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies (2005) Epilepsia, 46 (SUPPL. 9), pp. 140-148. , DOI 10.1111/j.1528-1167.2005.00326.xBerlin, A., Dahlstrom, H., Pharmacokinetics of the anticonvulsant drug clonazepam evaluated from single oral and intravenous doses and repeated oral administration (1975) Eur J Clin Pharmacol, 9, pp. 155-159Gomora, J.C., Daud, A.N., Weiergraber, M., Block of cloned human T-type calcium channels by succinimide antiepileptic drugs (2001) Mol Pharmacol, 60, pp. 1121-1132Pisani, F., Narbone, M.C., Trunfio, C., Valproic acid - Ethosuximide interaction: A pharmacokinetic study (1984) Epilepsia, 25 (2), pp. 229-233Lees, G., Leach, M.J., Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex (1993) Brain Research, 612 (1-2), pp. 190-199. , DOI 10.1016/0006-8993(93)91660-KPatsalos, P.N., Perucca, E., Clinically important interactions in epilepsy: General features and interactions between antiepileptic drugs (2003) Lancet Neurol, 6, pp. 347-356Yuen, A.W.C., Land, G., Weatherley, B.C., Sodium valproate inhibits lamotrigine metabolism (1992) Br J Clin Pharmacol, 33, pp. 511-513Sabers, A., Ohman, I., Christensen, J., Tomson, T., Oral contraceptives reduce lamotrigine plasma levels (2003) Neurology, 61 (4), pp. 570-571Patsalos, P.N., The mechanism of action of topiramate (1999) Rev Contemp Pharmacother, 10, pp. 147-153Bialer, M., Doose, D.R., Murthy, B., Pharmacokinetic interactions of topiramate (2004) Clin Pharmacokinet, 43, pp. 763-780Marson, A.G., Al-Kharusi, A.M., Alwaidh, M., Appleton, R., Baker, G.A., Chadwick, D.W., Cramp, C., Williamson, P.R., The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: An unblinded randomised controlled trial (2007) Lancet, 369 (9566), pp. 1016-1026. , DOI 10.1016/S0140-6736(07)60461-9, PII S0140673607604619Benbadis, S.R., Practical management issues for idiopathic generalized epilepsies (2005) Epilepsia, 46 (SUPPL. 9), pp. 125-132. , DOI 10.1111/j.1528-1167.2005.00324.xBuchanan, N., The use of lamotrigine in juvenile myoclonic epilepsy (1996) Seizure, 5 (2), pp. 149-151Obeid, T., Panayiotopoulos, C.P., Clonazepan in juvenile myoclonic epilepsy (1989) Epilepsia, 30, pp. 603-606Janz, D., Durner, M., Juvenile myoclonic epilepsy (1997) Epilepsy: A Comprehensive Textbook, pp. 2389-2400. , Engel JJ, Pedley TA, eds. Philadelphia: Lippincott-RavenJanz, D., Epilepsy with grand mal on awakening and sleep-waking cycle (2000) Clinical Neurophysiology, 111 (SUPPL. 2), pp. S103-S110. , DOI 10.1016/S1388-2457(00)00409-0, PII S1388245700004090Beran, R.G., Berkovic, S.F., Dunagan, F.M., Vajda, F.J.E., Danta, G., Black, A.B., Mackenzie, R., Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy (1998) Epilepsia, 39 (12), pp. 1329-1333. , DOI 10.1111/j.1528-1157.1998.tb01332.xBiton, V., Montouris, G.D., Ritter, F., Riviello, J.J., Reife, R., Lim, P., Pledger, G., A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures (1999) Neurology, 52 (7), pp. 1330-1337Glauser, T., Ben-Menachem, E., Bourgeois, B., Cnaan, A., Chadwick, D., Guerreiro, C., Kalviainen, R., Tomson, T., ILAE treatment guidelines: Evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes (2006) Epilepsia, 47 (7), pp. 1094-1120. , DOI 10.1111/j.1528-1167.2006.00585.xWheless, J.W., Acute management of seizures in the syndromes of idiopathic generalized epilepsies (2003) Epilepsia, 44 (SUPPL. 2), pp. 22-26. , DOI 10.1046/j.1528-1157.44.s.2.5.x